Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Changmao Biochemical Engineering Co gives H1 2014 earnings guidance


Thursday, 3 Jul 2014 05:00am EDT 

Changmao Biochemical Engineering Co Ltd:Sees H1 2014 to record a decline in the consolidated net profits as compared to the consolidated net profits for H1 2013.Financial performance has been affected mainly by decline in sales volume of some organic acid products compared to that in corresponding period in 2013 and fair value loss on derivative financial instruments that are used to hedge the sales of the Group that are denominated in US dollars. 

Company Quote

1.03
-0.01 -0.96%
19 Sep 2014